Literature DB >> 11150590

Catalytic and fibrinolytic properties of recombinant urokinase plasminogen activator from E. coli, mammalian, and yeast cells.

P Wang1, J Zhang, Z Sun, Y Chen, V Gurewich, J N Liu.   

Abstract

The enzymatic and fibrinolytic properties of glycosylated and nonglycosylated recombinant human pro-urokinase (pro-UK) produced in yeast Pichia pastoris were characterized and compared with those of Escherichia coli and mammalian cell-derived pro-UK. Among the five different forms of pro-UK, the yeast glycosylated pro-UK was activated by plasmin with the lowest catalytic efficiency (kcat/Km). The yeast glycosylated urokinase (UK) also had the highest Km in its activation of Glu-plasminogen, and had a substantially lower fibrinolytic activity than the other four forms. These findings suggest that the poly-mannose on Asn-302 of yeast glycosylated pro-UK interfered with its activation by plasmin and its binding interaction with plasminogen. By contrast to plasminogen, the activation of the small synthetic substrate, S2444, was comparable for all five forms of recombinant UK. It is concluded that the glycosyl residue on pro-UK/UK is functionally important and modulates its activatability and its catalytic efficiency against its natural substrate. Therefore, pro-UK from different expression systems cannot be assumed to have comparable fibrinolytic activities.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 11150590     DOI: 10.1016/s0049-3848(00)00349-2

Source DB:  PubMed          Journal:  Thromb Res        ISSN: 0049-3848            Impact factor:   3.944


  4 in total

1.  Asn and asn: critical residues for in vitro biological activity of reteplase.

Authors:  Naganath Mandi; Kalyana R Sundaram; Sunil K Tandra; Suman Bandyopadhyay; Sriram Padmanabhan
Journal:  Adv Hematol       Date:  2010-06-21

2.  Identification of cells responsible for urokinase-type plasminogen activator synthesis and secretion in human diploid kidney cell cultures.

Authors:  Safedin Beqaj; Anuja M Shah; Jon M Ryan
Journal:  In Vitro Cell Dev Biol Anim       Date:  2004 Mar-Apr       Impact factor: 2.416

3.  Development of a Mammalian suspension culture for expression of active recombinant human urokinase-type plasminogen activator.

Authors:  Erica Atkins; Stephanie Zamora; Britny J Candia; Amy Baca; Robert A Orlando
Journal:  Cytotechnology       Date:  2005-09       Impact factor: 2.058

4.  Aggregation and retention of human urokinase type plasminogen activator in the yeast endoplasmic reticulum.

Authors:  Michael O Agaphonov; Nina V Romanova; Polina M Trushkina; Vladimir N Smirnov; Michael D Ter-Avanesyan
Journal:  BMC Mol Biol       Date:  2002-10-07       Impact factor: 2.946

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.